header image

Take a look through our annual reports.

How to contact us for media/press enquiries.

Have a comment or question? Get in touch.


Press release - The Board of the Octapharma Group appoints Mr. Flemming Nielsen and Mr. Dennis Curtin as Members of the Board.


During the recent Board Meeting in April 2009, Mr. Flemming Nielsen and Mr. Dennis Curtin were appointed as members of the Octapharma Board effective July 1, 2009.  The appointments were made in recognition of each...

Press release - The French Health and Sports Minister grants the founder of the Octapharma Group, Mr. Wolfgang Marguerre, the French Legion of Honor during a visit to Octapharma' s facilities in Lingolsheim, France.


On April 18, 2009, the founder of the Octapharma Group, Mr. Wolfgang Marguerre, was granted “les insignes de Chevalier de la Légion d'Honneur”, the highest French military and civilian medal of Honor, by the French Minister of...

Press release - Octapharma AG Announces First-Ever Research Grants Program, Demonstrating Commitment to Cutting-Edge Clinical Research


Special Octapharma 25th Anniversary Program Will Support U.S. Research on Immunotherapy, Coagulation Disorders and intensive care and emergency medicine

Press release - Octapharma Results 2008


Lachen, Switzerland, 16 February 2009The year 2008 for Octapharma was focused on consolidation and introduction of our own plasma production, with investments exceeding €110 M. Against this perspective, for the fourth consecutive...

Press release - Octapharma starts phase II clinical study in Alzheimer's disease with octagam®10%


Lachen, Switzerland, 11 February 2009Octapharma AG announces the start of a phase II clinical trial following U.S. Food and Drug Administration (FDA) review of its investigational new drug application for octagam®10%, ...